Roche to reintroduce Susvimo in US for neovascular age-related macular degeneration Ruchika Sharma9 July 2024 1:00 PM ISTBasel: Roche has announced the reintroduction of Susvimo (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant for the...
Roche to halt lung cancer treatment trial Ruchika Sharma8 July 2024 5:43 PM ISTBased on these results, patients and investigators will be unblinded and we intend to halt the study.
Roche Vabysmo prefilled syringe bags USFDA nod for three causes of vision loss Ruchika Sharma6 July 2024 4:34 PM ISTVabysmo PFS delivers the same medicine as the currently available Vabysmo vials in an alternative, ready-to-use format.
Roche Vabysmo gets CHMP recommendation for third indication retinal vein occlusion Ruchika Sharma29 Jun 2024 10:00 AM ISTBasel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...
Roche unveils new analytical units for cobas pro integrated solutions in countries accepting CE mark Ruchika Sharma25 Jun 2024 11:30 AM ISTBasel: Roche has announced the launch of its new analytical units, cobas c 703 and cobas ISE neo, for the cobas pro integrated solutions, in...
Roche gets USFDA nod for chronic blood disorder treatment Crovalimab Ruchika Sharma23 Jun 2024 4:30 PM ISTRoche has received approval from the U.S. Food and Drug Administration (USFDA) for Crovalimab for the treatment of chronic blood...
Roche unveils new highly-sensitive B-cell lymphoma test Ruchika Sharma21 Jun 2024 1:45 PM ISTBasel: Roche has announced the launch of the clinically approved, highly-sensitive in-situ hybridisation (ISH) test, the VENTANA Kappa and Lambda...
USFDA grants Emergency Use Authorization for Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV Ruchika Sharma10 Jun 2024 3:26 PM ISTBasel: Roche announced today that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA)for its cobas liat...
Roche Alecensa gets European Commission nod as targeted adjuvant treatment for ALK-positive early-stage lung cancer Ruchika Sharma10 Jun 2024 10:00 AM ISTBasel: Roche announced today that the European Commission has approved Alecensa (alectinib) monotherapy, as adjuvant treatment following tumour...
Roche Inavolisib gets USFDA priority review for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation Ruchika Sharma29 May 2024 11:30 AM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application and granted Priority...
Head of Roche Pharma Partnering James Sabry to retire Ruchika Sharma27 May 2024 3:30 PM ISTBasel: Roche has announced that James Sabry (1958), Head of Roche Pharma Partnering, will be retiring after fourteen years with the company.James...
Roche gets USFDA Breakthrough Therapy Designation for Inavolisib for breast cancer with mutation Ruchika Sharma21 May 2024 2:30 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for inavolisib, an...
